ctrl K

AI Score

Unlock

Iterum Therapeutics (ITRM)

AI Score

Unlock

1.18

-0.05 (-4.07%)

At close: Apr 01, 2025, 3:59 PM

1.18

0.07%

After-hours: Apr 01, 2025, 05:27 PM EDT

Iterum Therapeutics Income Statement

Chart Mode

Year	FY24	FY23	FY22	FY21	FY20
Revenue	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	254K	1.75M	1.8M	2.1M	161K
Gross Profit	-254K	-1.75M	-1.8M	-2.1M	-161K
Operating Income	-18.7M	-47.47M	-30.38M	-24.54M	-32.13M
Interest Income	n/a	1.43M	2.36K	4.53K	12.3K
Pretax Income	-24.53M	-37.76M	-44.13M	-90.86M	-51.26M
Net Income	-24.77M	-38.37M	-44.43M	-91.56M	-52.01M
Selling & General & Admin	7.98M	7.48M	12.77M	13.82M	11.05M
Research & Development	10.46M	38.24M	17.62M	10.71M	21.07M
Other Expenses	n/a	n/a	-16.85M	195K	213K
Operating Expenses	18.44M	47.47M	30.38M	24.54M	32.13M
Interest Expense	-2.52M	n/a	2.36M	5.55M	15.1M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	18.7M	47.47M	30.38M	24.54M	32.13M
Income Tax	-240K	613K	301K	705K	743K
Shares Outstanding (Basic)	19.7M	12.96M	12.24M	163.37M	24.01M
Shares Outstanding (Diluted)	19.7M	12.96M	12.24M	163.37M	24.01M
EPS (Basic)	-1.26	-2.96	-3.63	-0.56	-2.17
EPS (Diluted)	n/a	n/a	n/a	n/a	n/a
EBITDA	-18.7M	-34.58M	-39.97M	-83.2M	-36.01M
Depreciation & Amortization	n/a	1.75M	1.8M	2.1M	161K